Cancer Gene Therapy
Researchers at Vall d'Hebron University, Medical Oncology Department release new data on cancer gene therapy
Published in Gene Therapy Weekly, February 26th, 2009
Fresh data on cancer gene therapy are presented in the report 'Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity.' "Lapatinib is a human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitor (TKI) that has clinical activity in HER2-amplified breast cancer. In vitro studies have shown that lapatinib enhances the effects of the monoclonal antibody trastuzumab suggesting partially non-overlapping mechanisms of action," scientists in Barcelona, Spain report.
"To dissect these mechanisms, we have studied the effects of lapatinib and trastuzumab on receptor...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2009-02-26)
More Articles from Gene Therapy Weekly
- Instituto Gulbenkian de Ciencia
Silencing of jumping genes in pollen - Scripps Research Institute
Team led by Scripps Scientists increases understanding of two types of blindness - Alzheimer Disease
Scientists at University of Brescia target Alzheimer disease - Apoptosis
Researchers from Columbia University report on findings in apoptosis - Apoptosis
Study data from University of Essen update knowledge of apoptosis - Arthritis
New arthritis study findings reported from T. Izumi and co-authors - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
